Reinventing cardiovascular management through connections that matter

To be able to prevent and possibly predict devastating health events like a heart attack, you need to have good connection with other people.  Family support and connections are key to helping patients impacted by health challenges. And I believe that if family members are equipped with more information about cardiovascular diseases such as hyperlipidemia, they can help patients take action to prevent health risks and overcome their conditions and become better. Through its partnership with Zuellig Pharma Corporation, Amgen Philippines Inc. looks forward in assisting us to improve our awareness of cardiovascular diseases (CVD) with educational initiatives to achieve the goal of changing the way the disease is managed and prevented.

Adult Cardiologist and Clinical Lipidologist Dr. Lourdes Ella Santos, answers media inquiries during the Q & A Session with the bloggers.

In the Philippines, there are over 130,000 deaths related to Cardiovascular disease in 2016 .  CVD is a complex disease with many risk factors that affects how it develops.  One such risk is dyslipidemia, which occurs when one has abnormal levels of lipids in the blood.  Lipids, or fats, are essential in providing energy to the cells while cholesterol is vital in the production of hormones and bile acids for healthy digestion.

There are two kinds of cholesterol in the body: “Bad” cholesterol and “good” cholesterol.  Elevated bad cholesterol, also known as low-density lipoprotein (LDL-C), in the blood increases a person’s risk of developing atherosclerotic plaque deposits which can block the arteries and lead to a heart attack or stroke.  Lowering LDL-C also lowers a person’s chances of developing CVD.

The standard treatment for lowering LDL-C are statins, but there are cases when statins are not enough.  Having access to new and innovative treatments in the management of dyslipidemia can make a difference for patients who are not able to achieve their lipid goals with statin alone.

With the patient at the heart of what we do, Amgen Philippines Inc. and Zuellig Pharma Corporation are committed to improving the lives of patients struggling with dyslipidemia by helping them and their families to take the necessary action to prevent and manage their health risks.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.